Healthcare Providers and Services
Company Overview of El Camino Hospital
El Camino Hospital operates acute-care hospitals that serve communities in the South San Francisco Bay area. It provides services in the areas of bariatric surgery, behavioral health, cancer, community health, corporate health, da Vinci surgical, dialysis, eating disorders, emergency, endoscopy, genomic medicine, heart and vascular, imaging, interventional pulmonology, laboratory, maternal-child health care, neuroscience, orthopedic, palliative care, pediatrics, and rehabilitation services; and robotic surgery, senior care, primary care, sleeping disorders, stroke, surgical, urology and men's health program, and women's health care services. The company was founded in 1958 and is based in Mo...
2500 Grant Road
Mountain View, CA 94040
Founded in 1958
Key Executives for El Camino Hospital
Chief Executive Officer and President
Vice President of Professional Corporate and Community Health Services and Chief Executive Officer of Concern
Compensation as of Fiscal Year 2014.
El Camino Hospital Key Developments
El Camino Hospital Announces Executive Changes
Feb 28 14
El Camino Hospital announced that it has appointed Iftikhar Hussain as the hospital's new Chief Financial Officer (CFO). Mr. Hussain will replace interim CFO, Ned Borgstrom, starting in April. Mr. Hussain previously served as the chief financial officer of Mills-Peninsula Health Services in Burlingame. Prior to his position at Mills-Peninsula Health Services, Mr. Hussain has held include Director of Finance at Alta Bates Summit Medical Center.
Strand Life Sciences Private Limited Collaborates with El Camino Hospital to Set Up Strand Center for Genomics and Personalized Medicine
Dec 5 13
Strand Life Sciences Private Limited is collaborating with El Camino Hospital to locate a Strand Center for Genomics and Personalized Medicine at the Genomic Medicine Institute of the El Camino Hospital to accelerate the adoption of next generation sequencing based research panels and counseling services by the physicians at the Hospital and its partner clinics.
El Camino Hospital Enrolls Second Patient in Global Clinical Trial Evaluating the Medtronic CoreValve(R) System in Intermediate Risk Patients with Aortic Valve Disease
Sep 11 13
El Camino Hospital, in partnership with the Taft Center for Clinical Research and the Fogarty Clinical Research Institute, both a part of the Fogarty Institute for Innovation, announced that it has enrolled its second patient in a global clinical trial comparing the Medtronic CoreValve(R) System with surgical aortic valve replacement in patients with severe aortic stenosis who are at intermediate risk for open-heart surgery. The Medtronic CoreValve Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) Trial is the large global, randomized, controlled trial to evaluate minimally-invasive transcatheter aortic valve implantation in less-sick patients who are typically treated with open-heart surgical aortic valve replacement (SAVR). The trial will evaluate whether the CoreValve System is non-inferior to surgical valve replacement based on the composite primary endpoint of all-cause mortality and disabling stroke at 24 months. Aortic stenosis occurs when the heart's aortic valve is narrowed, restricting blood flow from the heart to the body. The condition primarily affects older people and typically develops in individuals between the ages of 50 and 70, and research shows that, if left untreated, as many as 50% of aortic stenosis patients with severe symptoms may die within one year. Currently, the standard treatment for severe aortic stenosis, which affects approximately 300,000 people worldwide, is open-heart valve replacement surgery. However, due to possible health complications, one-third of these patients are considered ineligible for the procedure.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|